A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy

StatusActive, Not Recruiting
PhasePhase 2
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

  1. Study completion date: Jun 2025 to Aug 2025v3
  2. Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Primary completion date changed from estimate of Mar 2025 to Nov 18, 2024
    • Start date changed from estimate of Jul 2024 to Aug 11, 2024
    • Site contact updated
    v2
  3. Study First Submitted
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The study is being conducted to evaluate the efficacy, and safety of HRS-1893 for obstructive hypertrophic cardiomyopathy
Trial Details
NCT Number NCT06516068
Lead Sponsor Shandong Suncadia Medicine Co., Ltd.
Conditions
(from sponsor)		 Obstructive Hypertrophic Cardiomyopathy
Related terms Cardiomyopathy, Hypertrophic
Enrollment 42 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov